⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMNN News
Imunon, Inc. Common Stock
IMUNON to Hold Third Quarter 2025 Financial Results and Business Update Conference Call on Thursday, November 13, 2025
globenewswire.com
IMNN
IMUNON Announces Webcast of In-Person R&D Day Highlighting Progress on OVATION 3 Study in Pursuit of First Frontline Immunotherapy for Advanced Ovarian Cancer
globenewswire.com
IMNN
IMUNON to Present Phase 3 OVATION 3 Study of IMNN-001 in Advanced Ovarian Cancer at IGCS 2025 Annual Global Meeting
globenewswire.com
IMNN
IMUNON to Present New Translational Data from Phase 2 OVATION 2 Study of IMNN-001 at SITC 40th Annual Meeting
globenewswire.com
IMNN
IMUNON Invited to Present PlaCCine® DNA Technology Proof-of-Concept Data in Platform Presentations at Leading Vaccine Conferences
globenewswire.com
IMNN
IMUNON to Present Phase 3 Ovarian Cancer Study of IMNN-001 at ESMO Congress
globenewswire.com
IMNN